Positron-Emission Tomography
-
Subject Areas on Research
-
"I know that my role is going to change": a mixed-methods study of the relationship between amyloid-β PET scan results and caregiver burden.
-
"Now at least we have something to call it": Patient and care partner experiences receiving an amyloid PET scan.
-
(18)F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis.
-
(18)F-Flourodeoxy-Glucose PET/Computed Tomography in Brain Tumors: Value to Patient Management and Survival Outcomes.
-
(18)F-Fluorothymidine PET-CT for resected malignant gliomas before radiotherapy: tumor extent according to proliferative activity compared with MRI.
-
(18)F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study.
-
18F FDG PET/CT and Head and Neck Cancer: Patient Management and Outcomes.
-
18F-EF5 PET imaging as an early response biomarker for the hypoxia-activated prodrug SN30000 combined with radiation treatment in a non-small cell lung cancer xenograft model.
-
18F-FDG PET/CT Metabolic Tumor Volume and Intratumoral Heterogeneity in Pancreatic Adenocarcinomas: Impact of Dual-Time Point and Segmentation Methods.
-
18F-FDG PET/CT and lung cancer: value of fourth and subsequent posttherapy follow-up scans for patient management.
-
18F-FDG PET/CT in primary central nervous system lymphoma in HIV-negative patients.
-
18F-FDG-PET/CT therapy assessment of locally advanced pancreatic adenocarcinoma: impact on management and utilization of quantitative parameters for patient survival prediction.
-
18F-florbetapir Positron Emission Tomography-determined Cerebral β-Amyloid Deposition and Neurocognitive Performance after Cardiac Surgery.
-
18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.
-
2-Deoxy-2-[18F] Fluoro-d-Glucose PET/Computed Tomography: Therapy Response Assessment in Head and Neck Cancer.
-
3'-Deoxy-3'-[F-18]fluorothymidine positron emission tomography in patients with recurrent glioblastoma multiforme: comparison with Gd-DTPA enhanced magnetic resonance imaging.
-
A Case with Purine Nucleoside Phosphorylase Deficiency Suffering from Late-Onset Systemic Lupus Erythematosus and Lymphoma.
-
A General Cutoff Level Combined With Personalized Dynamic Change of Serum Carcinoembryonic Antigen Can Suggest Timely Use of FDG PET for Early Detection of Recurrent Colorectal Cancer.
-
A New, Second Generation Trithiol Bifunctional Chelate for 72,77As: Trithiol(b)-(Ser)2-RM2.
-
A Protocol for Sedation Free MRI and PET Imaging in Adults with Autism Spectrum Disorder.
-
A case of curative-intent hepatectomy for colon cancer metastatic to the scapula and liver.
-
A multicenter prospective evaluation of the clinical utility of F-18 FDG-PET/CT in patients with AJCC stage IIIB or IIIC extremity melanoma.
-
A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response.
-
A novel metric for quantification of homogeneous and heterogeneous tumors in PET for enhanced clinical outcome prediction.
-
A novel multi-relation regularization method for regression and classification in AD diagnosis.
-
A p-[18F]fluoroethoxyphenyl bicyclic nucleoside analogue as a potential positron emission tomography imaging agent for varicella-zoster virus thymidine kinase gene expression.
-
A phase II study of 2-methoxyestradiol (2ME2) NanoCrystal® dispersion (NCD) in patients with taxane-refractory, metastatic castrate-resistant prostate cancer (CRPC).
-
A programmable smoke delivery device for PET imaging with cigarettes containing 11C-nicotine.
-
A role for the CD38
rs3796863 polymorphism in alcohol and monetary reward: evidence from CD38 knockout mice and alcohol self-administration, [11C]-raclopride binding, and functional MRI in humans.
-
A simplified synthesis of the hypoxia imaging agent 2-(2-Nitro-1H-imidazol-1-yl)-N-(2,2,3,3,3-[(18)F]pentafluoropropyl)-acetamide ([18F]EF5).
-
A systematic review of the factors affecting accuracy of SUV measurements.
-
A technique of using gated-CT images to determine internal target volume (ITV) for fractionated stereotactic lung radiotherapy.
-
A trithiol bifunctional chelate for 72,77As: A matched pair theranostic complex with high in vivo stability.
-
ACR Appropriateness Criteria® Penetrating Trauma-Lower Abdomen and Pelvis.
-
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
-
ACR-ACNM-ASTRO-SNMMI Practice Parameter for Lutetium-177 (Lu-177) DOTATATE Therapy.
-
ACR-ASNR Practice Parameter for Brain PET/CT Imaging Dementia.
-
ACRIN 6684: Assessment of Tumor Hypoxia in Newly Diagnosed Glioblastoma Using 18F-FMISO PET and MRI.
-
ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
-
AJR teaching file: incidental breast cancer detected with 18F-FDG PET/CT.
-
AJR teaching file: left neck mass evaluated by PET/CT.
-
Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
-
Accuracy and generalization capability of an automatic method for the detection of typical brain hypometabolism in prodromal Alzheimer disease.
-
Accuracy of positron emission tomography in identifying hilar (N1) lymph node involvement in non-small cell lung cancer: Implications for stereotactic body radiation therapy.
-
Accurate event-driven motion compensation in high-resolution PET incorporating scattered and random events.
-
Accurate risk estimation of β-amyloid positivity to identify prodromal Alzheimer's disease: Cross-validation study of practical algorithms.
-
Adaptive planning using positron emission tomography for locally advanced lung cancer: A feasibility study.
-
Addition of 18F-FDG PET/CT to clinical assessment predicts overall survival in HNSCC: a retrospective analysis with follow-up for 12 years.
-
Adeno-Associated Viral Vector (Serotype 2)-Nerve Growth Factor for Patients With Alzheimer Disease: A Randomized Clinical Trial.
-
Adrenal nodules at FDG PET/CT in patients known to have or suspected of having lung cancer: a proposal for an efficient diagnostic algorithm.
-
Advance directives among cognitively impaired persons who had an amyloid PET scan and their care partners: a mixed-methods study.
-
Aggregated Tau Measured by Visual Interpretation of Flortaucipir Positron Emission Tomography and the Associated Risk of Clinical Progression of Mild Cognitive Impairment and Alzheimer Disease: Results From 2 Phase III Clinical Trials.
-
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
-
Altered prefrontal dopaminergic function in chronic recreational ketamine users.
-
Ameloblastic carcinoma of the mandible with metastasis to the skull and lung: advanced imaging appearance including computed tomography, magnetic resonance imaging and positron emission tomography computed tomography.
-
American College of Radiology and Society of Nuclear Medicine and Molecular Imaging Joint Credentialing Statement for PET/MR Imaging: Brain.
-
American Society of Clinical Oncology 2013 top five list in oncology.
-
Amyloid beta-positive subjects exhibit longitudinal network-specific reductions in spontaneous brain activity.
-
Amyloid deposition detected with florbetapir F 18 ((18)F-AV-45) is related to lower episodic memory performance in clinically normal older individuals.
-
Amyloid-β PET Scan Results Disclosure and Care-Partner Emotional Well-Being Over Time.
-
Amyloid-β assessed by florbetapir F 18 PET and 18-month cognitive decline: a multicenter study.
-
An Online Repository for Pre-Clinical Imaging Protocols (PIPs).
-
An assessment of the effects of shell cross-linked nanoparticle size, core composition, and surface PEGylation on in vivo biodistribution.
-
Anal Carcinoma, Version 2.2012: featured updates to the NCCN guidelines.
-
Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research.
-
Analysis of pretreatment FDG-PET SUV parameters in head-and-neck cancer: tumor SUVmean has superior prognostic value.
-
Analytical and biological methods for probing the blood-brain barrier.
-
Aortic regurgitation in Takayasu's arteritis.
-
Apolipoprotein E ε4 and age effects on florbetapir positron emission tomography in healthy aging and Alzheimer disease.
-
Approach to pediatric epilepsy surgery: State of the art, Part I: General principles and presurgical workup.
-
Are discordant positron emission tomography and pathological assessments of the mediastinum in non-small cell lung cancer significant?
-
Association Between Anticholinergic Medication Use and Cognition, Brain Metabolism, and Brain Atrophy in Cognitively Normal Older Adults.
-
Association Between Polygenic Risk Score and the Progression from Mild Cognitive Impairment to Alzheimer's Disease.
-
Association between amygdala reactivity and a dopamine transporter gene polymorphism.
-
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
-
Association of Cognitive and Behavioral Features Between Adults With Tuberous Sclerosis and Frontotemporal Dementia.
-
Association of Sleep and β-Amyloid Pathology Among Older Cognitively Unimpaired Adults.
-
Associations between dopamine D2 receptor availability and BMI depend on age.
-
Attenuation of counterregulatory responses to recurrent hypoglycemia by active thalamic inhibition: a mechanism for hypoglycemia-associated autonomic failure.
-
Authors' Reply.
-
Automated radiochemical synthesis and biodistribution of [¹¹C]l-α-acetylmethadol ([¹¹C]LAAM).
-
Autoregulation after ischaemic stroke.
-
Autoregulation of cerebral blood flow to changes in arterial pressure in mild Alzheimer's disease.
-
Better late than early: FDG-PET imaging in metastatic renal cell carcinoma.
-
Bevacizumab: radiation combination produces restricted diffusion on brain MRI.
-
Brain FDG PET and the diagnosis of dementia.
-
Brain PET in the diagnosis of Alzheimer's disease.
-
Brain connectivity and visual attention.
-
Brain nicotinic acetylcholine receptor availability and response to smoking cessation treatment: a randomized trial.
-
Brain nicotinic acetylcholine receptor occupancy: effect of smoking a denicotinized cigarette.
-
Brain trauma, PET scans and forensic complexity.
-
Can we improve the identification of ventricular scar to guide substrate-based ventricular tachycardia ablation?
-
Canonical feature selection for joint regression and multi-class identification in Alzheimer's disease diagnosis.
-
Capacity for 5-HT1A-mediated autoregulation predicts amygdala reactivity.
-
Cardiopulmonary transit time: Reinforcing the case for positron emission tomography after heart transplantation.
-
Cardiovascular PET/MR: We need evidence, not hype.
-
Cerebellum as the normal reference for the detection of increased cerebral oxygen extraction.
-
Cerebral Amyloid and Cognition after Surgery: Reply.
-
Cerebral hemodynamics and cognitive impairment: baseline data from the RECON trial.
-
Cerebral mitochondrial metabolism in early Parkinson's disease.
-
Changes in Aβ biomarkers and associations with APOE genotype in 2 longitudinal cohorts.
-
Changes in brain function occur years before the onset of cognitive impairment.
-
Characteristic patterns of inter- and intra-hemispheric metabolic connectivity in patients with stable and progressive mild cognitive impairment and Alzheimer's disease.
-
Characterization of 3-Dimensional PET Systems for Accurate Quantification of Myocardial Blood Flow.
-
Cigarette smoking saturates brain alpha 4 beta 2 nicotinic acetylcholine receptors.
-
Classification and evaluation strategies of auto-segmentation approaches for PET: Report of AAPM task group No. 211.
-
Clinical Impact of ASCO Choosing Wisely Guidelines on Staging Imaging for Early-Stage Breast Cancers: A Time Series Analysis Using SEER-Medicare Data.
-
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.
-
Clinical Quantification of Myocardial Blood Flow Using PET: Joint Position Paper of the SNMMI Cardiovascular Council and the ASNC.
-
Clinical practice guidance for radiotherapy planning after induction chemotherapy in locoregionally advanced head-and-neck cancer.
-
Clinical significance of diffusely increased 18F-FDG uptake in the thyroid gland.
-
Clinical stage I non-small cell lung cancer including FDG-PET Imaging: sites and time to recurrence.
-
Clustered Arg–Gly–Asp peptides enhances tumor targeting of nonviral vectors
-
Clustering-induced multi-task learning for AD/MCI classification.
-
Co-clinical trials demonstrate superiority of crizotinib to chemotherapy in ALK-rearranged non-small cell lung cancer and predict strategies to overcome resistance.
-
Cognitive impact of genetic variation of the serotonin transporter in primates is associated with differences in brain morphology rather than serotonin neurotransmission.
-
Colocalization of gadolinium-diethylene triamine pentaacetic acid with high-molecular-weight molecules after intracerebral convection-enhanced delivery in humans.
-
Colonic schwannoma visualized on FDG PET/CT.
-
Combined deletion of Glut1 and Glut3 impairs lung adenocarcinoma growth.
-
Combining multiple FDG-PET radiotherapy target segmentation methods to reduce the effect of variable performance of individual segmentation methods.
-
Commentary on "Positron Emission Tomography in the Lung" 25 years after publication in the inaugural issue of the Journal of Thoracic Imaging.
-
Commentary on imaging of bronchogenic carcinoma.
-
Comparative characteristics of primary hyperparathyroidism in pediatric and young adult patients.
-
Comparison of the Hypoxia PET Tracer (18)F-EF5 to Immunohistochemical Marker EF5 in 3 Different Human Tumor Xenograft Models.
-
Complete Evaluation of Dementia: PET and MRI Correlation and Diagnosis for the Neuroradiologist.
-
Comprehensive nutrient consumption estimation and metabolic profiling during ketogenic diet and relationship with myocardial glucose uptake on FDG-PET.
-
Concurrent chemoradiotherapy for locally advanced, nonmetastatic, squamous carcinoma of the head and neck: consensus, controversy, and conundrum.
-
Concurrent tracking of anatomy and metabolism.
-
Connect MM Registry: The Importance of Establishing Baseline Disease Characteristics.
-
Consensus recommendations for the use of 18F-FDG PET as an indicator of therapeutic response in patients in National Cancer Institute Trials.
-
Continuing education course #1: non-invasive imaging as a problem-solving tool and translational biomarker strategy in toxicologic pathology.
-
Continuity of care (COC) and amyloid-β PET scan: the CARE-IDEAS study.
-
Contouring variations and the role of atlas in non-small cell lung cancer radiation therapy: Analysis of a multi-institutional preclinical trial planning study.
-
Contribution of F-18 FDG PET-CT in the detection of systemic spread of primary central nervous system lymphoma.
-
Correlation of [18F]-2-fluoro-deoxy-D-glucose positron emission tomography standard uptake values with the cellular composition of stage I nonsmall cell lung cancer.
-
Correspondence between in vivo (11)C-PiB-PET amyloid imaging and postmortem, region-matched assessment of plaques.
-
Current trends in regional therapy for melanoma: lessons learned from 225 regional chemotherapy treatments between 1995 and 2010 at a single institution.
-
Current worldwide nuclear cardiology practices and radiation exposure: results from the 65 country IAEA Nuclear Cardiology Protocols Cross-Sectional Study (INCAPS).
-
Cutaneous γδ T-cell lymphomas: a spectrum of presentations with overlap with other cytotoxic lymphomas.
-
Deep learning based imaging data completion for improved brain disease diagnosis.
-
Deep sparse multi-task learning for feature selection in Alzheimer's disease diagnosis.
-
Deformable registration of preoperative PET/CT with postoperative radiation therapy planning CT in head and neck cancer.
-
Detection of primary breast carcinoma with a dedicated, large-field-of-view FDG PET mammography device: initial experience.
-
Development of Novel 18
F-PET Agents for Tumor Hypoxia Imaging.
-
Development of scalable lymphatic system in the 4D XCAT phantom: Application to quantitative evaluation of lymphoma PET segmentations.
-
Diagnosing pulmonic valve infective endocarditis with positron emission tomography-CT.
-
Diagnostic Accuracy of Follow-Up FDG PET or PET/CT in Patients With Head and Neck Cancer After Definitive Treatment: A Systematic Review and Meta-Analysis.
-
Diagnostic accuracy of SPECT and PET myocardial perfusion imaging in patients with left bundle branch block or ventricular-paced rhythm.
-
Diagnostic accuracy of noninvasive testing: necessary but insufficient.
-
Differential regional decline in dopamine receptor availability across adulthood: Linear and nonlinear effects of age.
-
Diffusion Tensor MRI Structural Connectivity and PET Amyloid Burden in Preclinical Autosomal Dominant Alzheimer Disease: The DIAN Cohort.
-
Digital anthropomorphic phantoms of non-rigid human respiratory and voluntary body motion for investigating motion correction in emission imaging.
-
Dissociation Between Hormonal Counterregulatory Responses and Cerebral Glucose Metabolism During Hypoglycemia.
-
Divergent Interpretations of Imaging After Stereotactic Body Radiation Therapy for Lung Cancer.
-
Does computed tomography or positron emission tomography response after neoadjuvant chemotherapy for resectable non-small-cell lung cancer predict survival?
-
Does myocardial perfusion imaging provide incremental prognostic information to left ventricular ejection fraction?
-
Dopamine in amygdala gates limbic processing of aversive stimuli in humans.
-
Dopamine-modulated aversive emotion processing fails in alcohol-dependent patients.
-
Dose-dependent effects of radiation therapy on cerebral blood flow, metabolism, and neurocognitive dysfunction.
-
Dosimetry and radiographic analysis of 131I-labeled anti-tenascin 81C6 murine monoclonal antibody in newly diagnosed patients with malignant gliomas: a phase II study.
-
Doxorubicin, vinblastine, and gemcitabine (CALGB 50203) for stage I/II nonbulky Hodgkin lymphoma: pretreatment prognostic factors and interim PET.
-
Dramatic increase in autism prevalence parallels explosion of research into its biology and causes.
-
Early detection of pemetrexed-induced inhibition of thymidylate synthase in non-small cell lung cancer with FLT-PET imaging.
-
Early effects of imatinib mesylate on the expression of insulin-like growth factor binding protein-3 and positron emission tomography in patients with gastrointestinal stromal tumor.
-
Early post transplant (F-18) 2-fluoro-2-deoxyglucose positron emission tomography does not predict outcome for patients undergoing auto-SCT in non-Hodgkin and Hodgkin lymphoma.
-
Early response monitoring of receptor tyrosine kinase inhibitor therapy in metastatic renal cell carcinoma using [F-18]fluorothymidine-positron emission tomography-magnetic resonance.
-
Early role of vascular dysregulation on late-onset Alzheimer's disease based on multifactorial data-driven analysis.
-
Effect of High-Dose Simvastatin on Cerebral Blood Flow and Static Autoregulation in Subarachnoid Hemorrhage.
-
Effect of Immunosuppressive Therapy and Biopsy Status in Monitoring Therapy Response in Suspected Cardiac Sarcoidosis.
-
Effect of hyperoxia on cerebral metabolic rate for oxygen measured using positron emission tomography in patients with acute severe head injury.
-
Effect of normal saline bolus on cerebral blood flow in regions with low baseline flow in patients with vasospasm following subarachnoid hemorrhage.
-
Effect of secondhand smoke on occupancy of nicotinic acetylcholine receptors in brain.
-
Effectiveness of Florbetapir PET Imaging in Changing Patient Management.
-
Efficacy of mediastinal lymph node dissection during lobectomy for lung cancer by thoracoscopy and thoracotomy.
-
Efficient purification and metabolite analysis of radiotracers using high-performance liquid chromatography and on-line solid-phase extraction.
-
Elective nodal irradiation for locally advanced non-small-cell lung cancer: it's called cancer for a reason.
-
Emerging role of positron emission tomography (PET) imaging in cardiac surgery.
-
Enhancing ejection fraction measurement through 4D respiratory motion compensation in cardiac PET imaging.
-
Estimation of D2-like receptor occupancy by dopamine in the putamen of hemiparkinsonian Monkeys.
-
Evaluating Alzheimer Disease With Flortaucipir and Florbetapir PET: A Clinical Case Series.
-
Evaluating dopamine reward pathway in ADHD: clinical implications.
-
Evaluation of 18F-FDG PET and MRI associations in pediatric diffuse intrinsic brain stem glioma: a report from the Pediatric Brain Tumor Consortium.
-
Evaluation of 5-(2-(4-pyridinyl)vinyl)-6-chloro-3-(1-methyl-2-(S)-pyrrolidinylmethoxy)pyridine and its analogues as PET radioligands for imaging nicotinic acetylcholine receptors.
-
Evaluation of 72Se/72As generator and production of 72Se for supplying 72As as a potential PET imaging radionuclide.
-
Evidence for brain glial activation in chronic pain patients.
-
Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition).
-
Evolving role of FDG PET/CT in multiple myeloma imaging and management.
-
Exercise heart rates in patients with hypertrophic cardiomyopathy.
-
Extracranial-intracranial bypass surgery for stroke prevention in hemodynamic cerebral ischemia: the Carotid Occlusion Surgery Study randomized trial.
-
F-18 FDG PET/CT imaging of a hidradenocarcinoma of head and neck.
-
F-18 FDG PET/CT imaging of a parapharyngeal hemangioma.
-
F-18 FDG PET/CT imaging of endogenous Cushing syndrome.
-
F-18 FDG PET/CT imaging of intraventricular germinoma.
-
F-18 FDG PET/CT imaging of submandibular gland oncocytoma.
-
F-18-FDG-PET/CT imaging of small cell carcinoma of the colon.
-
FDG Avidity and Tumor Burden: Survival Outcomes for Patients With Recurrent Breast Cancer.
-
FDG PET metabolic tumor volume segmentation and pathologic volume of primary human solid tumors.
-
FDG PET/CT for Management and Assessing Outcomes of Squamous Cell Cancer of the Oral Cavity.
-
FDG PET/CT for Primary Staging of Lung Cancer and Mesothelioma.
-
FDG PET/CT imaging of oropharyngeal squamous cell carcinoma: characteristics of human papillomavirus-positive and -negative tumors.
-
FDG PET/CT in Pancreatic and Hepatobiliary Carcinomas: Value to Patient Management and Patient Outcomes.
-
FDG PET/CT in Patients With Head and Neck Squamous Cell Carcinoma After Primary Surgical Resection With or Without Chemoradiation Therapy.
-
FDG PET/CT in patients with HIV.
-
FDG PET/CT in the management of colorectal and anal cancers.
-
FDG PET/CT in the management of nasopharyngeal carcinoma.
-
FDG PET/CT in the management of primary pleural tumors and pleural metastases.
-
FDG PET/CT interobserver agreement in head and neck cancer: FDG and CT measurements of the primary tumor site.
-
FDG PET/CT of carcinoma showing thymus-like differentiation.
-
FDG Uptake on Positron Emission Tomography Correlates with Survival and Time to Recurrence in Patients with Stage I Non-Small-Cell Lung Cancer.
-
FDG volumetric parameters and survival outcomes after definitive chemoradiotherapy in patients with recurrent head and neck squamous cell carcinoma.
-
FDG-PET assessment of the effect of head and neck radiotherapy on parotid gland glucose metabolism.
-
FDG-PET for management of cervical and ovarian cancer.
-
FDG-PET imaging in patients with pulmonary carcinoid tumor.
-
FDG-PET/CT characterization of adrenal nodules: diagnostic accuracy and interreader agreement using quantitative and qualitative methods.
-
FTO affects food cravings and interacts with age to influence age-related decline in food cravings.
-
Feasibility of optimizing the dose distribution in lung tumors using fluorine-18-fluorodeoxyglucose positron emission tomography and single photon emission computed tomography guided dose prescriptions.
-
Fetal gene transfer with lentiviral vectors: long-term in vivo follow-up evaluation in a rat model.
-
Financial Management Skills in Aging, MCI and Dementia: Cross Sectional Relationship to 18F-Florbetapir PET Cortical β-amyloid Deposition.
-
Florbetapir (F18-AV-45) PET to assess amyloid burden in Alzheimer's disease dementia, mild cognitive impairment, and normal aging.
-
Florbetapir F 18 amyloid PET and 36-month cognitive decline: a prospective multicenter study.
-
Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation.
-
Fluorine-18 Labeling of the MDM2 Inhibitor RG7388 for PET Imaging: Chemistry and Preliminary Evaluation.
-
Fluorodeoxyglucose positron emission tomography/computerized tomography in differentiated thyroid cancer management: Importance of clinical justification and value in predicting survival.
-
Fluorodeoxyglucose-positron-emission tomography imaging of head and neck squamous cell cancer.
-
Focal F-18 fluoro-deoxy-glucose accumulation in the lung parenchyma in the absence of CT abnormality in PET/CT.
-
Follow-up FDG PET/CT in Patients With Non-Hodgkin Lymphoma: Value to Clinical Assessment and Patient Management.
-
Follow-up or Surveillance (18)F-FDG PET/CT and Survival Outcome in Lung Cancer Patients.
-
Four-dimensional image-based treatment planning: Target volume segmentation and dose calculation in the presence of respiratory motion.
-
Full central neurokinin-1 receptor blockade is required for efficacy in depression: evidence from orvepitant clinical studies.
-
Functional and molecular image guidance in radiotherapy treatment planning optimization.
-
Functional expression of sodium-glucose transporters in cancer.
-
Gender Differences in Radiation Dose From Nuclear Cardiology Studies Across the World: Findings From the INCAPS Registry.
-
Genetic variation in HTR2A influences serotonin transporter binding potential as measured using PET and [11C]DASB.
-
Getting on Message: Preventing Alzheimer Disease Through Diet and Exercise.
-
Giant cell arteritis mimicking infiltrative leptomeningeal disease of the optic nerves.
-
Greater nicotinic acetylcholine receptor density in smokers than in nonsmokers: a PET study with 2-18F-FA-85380.
-
Head and Neck Cancer and PET/Computed Tomography.
-
Head and neck PET/CT: therapy response interpretation criteria (Hopkins Criteria)-interreader reliability, accuracy, and survival outcomes.
-
Head and neck cancer as a model for advances in imaging prognosis, early assessment, and posttherapy evaluation.
-
Head and neck cancer: dedicated FDG PET/CT protocol for detection--phantom and initial clinical studies.
-
Hemispheric asymmetry of sulcus-function correspondence: quantization and developmental implications.
-
Hibernoma: 18F FDG PET/CT imaging.
-
Hierarchical feature representation and multimodal fusion with deep learning for AD/MCI diagnosis.
-
Hodgkin lymphoma, version 2.2012 featured updates to the NCCN guidelines.
-
Hodgkin lymphoma, version 2.2015.
-
Hospice Admission and Survival After 18
F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.
-
How Accurately Do Patients and Their Care Partners Report Results of Amyloid-β PET Scans for Alzheimer's Disease Assessment?
-
How Good Is Positron Emission Tomography at Detecting Previously-Occult Metastatic Lung Cancer at Diagnosis?
-
Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond.
-
Hybrid PET/MR: State-of-the-Art and Future Challenges.
-
I-131, I-123, and F-18 FDG-PET imaging in a patient with diffuse sclerosing variant of papillary thyroid cancer.
-
IV Contrast Material for PET/CT: Point-Putting the CT Into PET/CT.
-
Identification of distant metastases with PET-CT in patients with suspected recurrent head and neck cancer.
-
Identification of distant metastases with positron-emission tomography-computed tomography in patients with previously untreated head and neck cancer.
-
Imaging biomarker roadmap for cancer studies.
-
Imaging for assessment of radiation-induced normal tissue effects.
-
Imaging genetics of brain longevity and mental wellness: the next frontier?
-
Imaging of musculoskeletal bacterial infections by [124I]FIAU-PET/CT.
-
Imaging of primary and secondary renal lymphoma.
-
Imaging tumors of the penis and urethra.
-
Imaging-guided preoperative hookwire localization of nonpalpable extramammary lesions.
-
Immunotherapeutic Targeting and PET Imaging of DLL3 in Small-Cell Neuroendocrine Prostate Cancer.
-
Impact of Neck PET/CT Positivity on Survival Outcomes-Visual and Quantitative Assessment: Results From ACRIN 6685.
-
Impact of concurrent diagnostic level CT with PET/CT on the utilization of stand-alone CT and MRI in the management of head and neck cancer patients.
-
Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging.
-
Impact of point spread function reconstruction on quantitative 18F-FDG-PET/CT imaging parameters and inter-reader reproducibility in solid tumors.
-
Impact of pre-operative positron emission tomography in gallbladder cancer.
-
Impact of short access nicotine self-administration on expression of α4β2* nicotinic acetylcholine receptors in non-human primates.
-
Impact of ¹⁸F-florbetapir PET imaging of β-amyloid neuritic plaque density on clinical decision-making.
-
Impact on Patient Management of [18F]-Fluorodeoxyglucose-Positron Emission Tomography (PET) Used for Cancer Diagnosis: Analysis of Data From the National Oncologic PET Registry.
-
Impaired glucose tolerance in midlife and longitudinal changes in brain function during aging.
-
Improved cardiac risk assessment with noninvasive measures of coronary flow reserve.
-
Improved tumor targeting of anti-HER2 nanobody through N-succinimidyl 4-guanidinomethyl-3-iodobenzoate radiolabeling.
-
Improving outcomes in advanced DLBCL: systemic approaches and radiotherapy.
-
Improving the rates of Aspergillus detection: an update on current diagnostic strategies.
-
In Reply to Giron et al.
-
In vivo fibrillar beta-amyloid detected using [11C]PiB positron emission tomography and neuropathologic assessment in older adults.
-
In vivo noninvasive detection of Brown Adipose Tissue through intermolecular zero-quantum MRI.
-
In vivo treatment sensitivity testing with positron emission tomography/computed tomography after one cycle of chemotherapy for Hodgkin lymphoma.
-
Incidence and patterns of neuraxis metastases in children with diffuse pontine glioma.
-
Incidental, subsolid pulmonary nodules at CT: etiology and management.
-
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis Progression.
-
Increasing PET Use in Small Cell Lung Cancer: Survival Improvement and Stage Migration in the VA Central Cancer Registry.
-
Increasing uptake time in FDG-PET: standardized uptake values in normal tissues at 1 versus 3 h.
-
Increasing use of positron emission tomography among medicare beneficiaries undergoing radical cystectomy.
-
Incremental prognostic value of visually estimated coronary artery calcium in patients undergoing positron emission tomography imaging.
-
Individual Differences in Dopamine Are Associated with Reward Discounting in Clinical Groups But Not in Healthy Adults.
-
Individual differences in dopamine D2 receptor availability correlate with reward valuation.
-
Influence of filter choice on 18F-FDG PET segmentation accuracy determined using generalized estimating equations.
-
Initial Performance of NI-RADS to Predict Residual or Recurrent Head and Neck Squamous Cell Carcinoma.
-
Integration of PET/MR Hybrid Imaging into Radiation Therapy Treatment.
-
Intended Versus Inferred Treatment After 18F-Fluoride PET Performed for Evaluation of Osseous Metastatic Disease in the National Oncologic PET Registry.
-
Interesting image. F-18 fluorodeoxyglocose positron emission tomography/computed tomography in the diagnosis of chronic myopathic sarcoidosis.
-
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?
-
Interpretation and reporting of positron emission tomography-computed tomographic scans.
-
Interreader agreement and variability of FDG PET volumetric parameters in human solid tumors.
-
Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
-
Intra-Target Microdosing - A Novel Drug Development Approach: Proof of Concept, Safety, and Feasibility Study in Humans.
-
Intra-reader reliability of FDG PET volumetric tumor parameters: effects of primary tumor size and segmentation methods.
-
Intraarterial Microdosing: A Novel Drug Development Approach, Proof-of-Concept PET Study in Rats.
-
Intratherapy or Posttherapy FDG PET or FDG PET/CT for Patients With Head and Neck Cancer: A Systematic Review and Meta-analysis of Prognostic Studies.
-
Intratreatment Response Assessment With 18F-FDG PET: Correlation of Semiquantitative PET Features With Pathologic Response of Esophageal Cancer to Neoadjuvant Chemoradiotherapy.
-
Is follow-up CT imaging of the chest and abdomen necessary after preoperative neoadjuvant therapy in rectal cancer patients without evidence of metastatic disease at diagnosis?
-
Ivory vertebra on 18F-sodium fluoride scan: an old sign in a new modality.
-
Journal Club: incidental thyroid nodules detected at imaging: can diagnostic workup be reduced by use of the Society of Radiologists in Ultrasound recommendations and the three-tiered system?
-
Kaposi sarcoma after bilateral lung transplantation.
-
Kinetics of brain nicotine accumulation in dependent and nondependent smokers assessed with PET and cigarettes containing 11C-nicotine.
-
Lack of consistent sex differences in D-amphetamine-induced dopamine release measured with [18
F]fallypride PET.
-
Late Gadolinium Enhancement Cardiac Magnetic Resonance Tissue Characterization for Cancer-Associated Cardiac Masses: Metabolic and Prognostic Manifestations in Relation to Whole-Body Positron Emission Tomography.
-
Letter by Powers Regarding Article, "Failure of cerebral hemodynamic selection in general or of specific positron emission tomography methodology? Carotid occlusion surgery study (COSS)".
-
Leveraging Coupled Interaction for Multimodal Alzheimer's Disease Diagnosis.
-
Linking dementia research to policy: an example using fluorodeoxyglucose positron emission tomography for the diagnosis of Alzheimer's dementia and mild cognitive impairment.
-
Linking variability in brain chemistry and circuit function through multimodal human neuroimaging.
-
Liposomal 64Cu-PET Imaging of Anti-VEGF Drug Effects on Liposomal Delivery to Colon Cancer Xenografts.
-
Liver SULmean at FDG PET/CT: interreader agreement and impact of placement of volume of interest.
-
Liver standardized uptake value corrected for lean body mass at FDG PET/CT: effect of FDG uptake time.
-
Long-term stimulant treatment affects brain dopamine transporter level in patients with attention deficit hyperactive disorder.
-
Low-dose consolidation radiation therapy for early stage unfavorable Hodgkin lymphoma.
-
Lower-dose vs high-dose oral estradiol therapy of hormone receptor-positive, aromatase inhibitor-resistant advanced breast cancer: a phase 2 randomized study.
-
Lung Cancers Associated With Cystic Airspaces: Natural History, Pathologic Correlation, and Mutational Analysis.
-
MAPT rs242557 variant is associated with hippocampus tau uptake on 18F-AV-1451 PET in non-demented elders.
-
MIBG scans in patients with stage 4 neuroblastoma reveal two metastatic patterns, one is associated with MYCN amplification and in MYCN-amplified tumours correlates with a better prognosis.
-
MR imaging and PET/CT in diagnosis and management of multiple myeloma.
-
MR imaging of oxygen extraction and neurovascular coupling.
-
MR-PET co-registration in upper abdominal imaging: quantitative comparison of two different T1-weighted gradient echo sequences: initial observations.
-
MR-PET evaluation of 1-month post-ablation therapy for hepatocellular carcinoma: preliminary observations.
-
MRI Evaluation of the Response of Rectal Cancer to Neoadjuvant Chemoradiation Therapy.
-
MRI for the assessment of myocardial viability.
-
Mapping the effects of ApoE4, age and cognitive status on 18F-florbetapir PET measured regional cortical patterns of beta-amyloid density and growth.
-
Measurement of the alpha4beta2* nicotinic acetylcholine receptor ligand 2-[(18)F]Fluoro-A-85380 and its metabolites in human blood during PET investigation: a methodological study.
-
Mechanistic Insights into Sympathetic Neuronal Regeneration: Multitracer Molecular Imaging of Catecholamine Handling After Cardiac Transplantation.
-
Melanoma-associated retinopathy: a presenting sign of metastatic disease.
-
Mesolimbic dopamine D2 receptors and neural representations of subjective value.
-
Meta-analysis: the detection of pancreatic malignancy with positron emission tomography.
-
Meta-iodobenzylguanidine and analogues: chemistry and biology.
-
Metabolic control of resting hemispheric cerebral blood flow is oxidative, not glycolytic.
-
Metastatic melanoma to the heart.
-
Methylphenidate-elicited dopamine increases in ventral striatum are associated with long-term symptom improvement in adults with attention deficit hyperactivity disorder.
-
Midlife adiposity predicts earlier onset of Alzheimer's dementia, neuropathology and presymptomatic cerebral amyloid accumulation.
-
Modeling pathologic response of esophageal cancer to chemoradiation therapy using spatial-temporal 18F-FDG PET features, clinical parameters, and demographics.
-
Molecular Imaging and Precision Medicine in Head and Neck Cancer.
-
Molecular Imaging in the Head and Neck: Diagnosis and Therapy.
-
Molecular PET imaging in multicenter Alzheimer's therapeutic trials: current trends and implementation strategies.
-
Molecular imaging for depressive disorders.
-
Molecular imaging in Alzheimer's disease.
-
Molecular imaging of hypoxia.
-
Motivation deficit in ADHD is associated with dysfunction of the dopamine reward pathway.
-
Multi-modality canonical feature selection for Alzheimer's disease diagnosis.
-
Multicenter phase II trial of topotecan, cisplatin and bevacizumab for recurrent or persistent cervical cancer.
-
Multimodal and Multiscale Deep Neural Networks for the Early Diagnosis of Alzheimer's Disease using structural MR and FDG-PET images.
-
Multimodal manifold-regularized transfer learning for MCI conversion prediction.
-
Multisphere phantom and analysis algorithm for PET image quality assessment.
-
Myocardial Energetics in Heart Failure With Preserved Ejection Fraction.
-
Myocardial Involvement in Patients With Histologically Diagnosed Cardiac Sarcoidosis: A Systematic Review and Meta-Analysis of Gross Pathological Images From Autopsy or Cardiac Transplantation Cases.
-
NIDA522131, a new radioligand for imaging extrathalamic nicotinic acetylcholine receptors: in vitro and in vivo evaluation.
-
Neuropathologic heterogeneity does not impair florbetapir-positron emission tomography postmortem correlates.
-
New advances in focal therapy for early stage prostate cancer.
-
New radiotherapy and chemoradiotherapy approaches for non-small-cell lung cancer.
-
No effect of low-dose statins treatment on cerebral blood flow in humans with atherosclerotic cerebrovascular disease.
-
Nuclear cardiology practice and associated radiation doses in Europe: results of the IAEA Nuclear Cardiology Protocols Study (INCAPS) for the 27 European countries.
-
Occult malignancy in patients with suspected paraneoplastic neurologic syndromes: value of positron emission tomography in diagnosis.
-
Oncogene pathway activation in mammary tumors dictates FDG-PET uptake.
-
Oncologic 18F-FDG PET/CT: referring physicians' point of view.
-
Oxygen metabolism in acute ischemic stroke.
-
PET Imaging of Dementia: Update 2022.
-
PET Imaging of Oral Cavity and Oropharyngeal Cancers.
-
PET and brain tumor image fusion.
-
PET appearance of tuberculous empyema necessitans.
-
PET of hypoxia and perfusion with 62Cu-ATSM and 62Cu-PTSM using a 62Zn/62Cu generator.
-
PET scanning in mild cognitive impairment.
-
PET studies of cerebral metabolism in Parkinson disease.
-
PET with 62Cu-ATSM and 62Cu-PTSM is a useful imaging tool for hypoxia and perfusion in pulmonary lesions.
-
PET with Fluorodeoxyglucose F 18/Computed Tomography in the Clinical Management and Patient Outcomes of Esophageal Cancer.
-
PET-CT: current applications and new developments in the thorax.
-
PET-based primary tumor volumetric parameters and survival of patients with non-small cell lung carcinoma.
-
PET-detected asymptomatic recurrence is associated with improved survival in recurrent cervical cancer.
-
PET/CT imaging and human papilloma virus-positive oropharyngeal squamous cell cancer: evolving clinical imaging paradigm.
-
PET/CT in the management of thyroid cancers.
-
PET/CT of cancer patients: part 1, pancreatic neoplasms.
-
PET/CT of cancer patients: part 2, deformable registration imaging before and after chemotherapy for radiation treatment planning in head and neck cancer.
-
PET/CT today and tomorrow in veterinary cancer diagnosis and monitoring: fundamentals, early results and future perspectives.
-
PET/CT: Adding Value to Patient Outcomes and Health Care Delivery.
-
PET/CT: Defining Value to Patients and Health Systems.
-
PET/Computed Tomography: Laryngeal and Hypopharyngeal Cancers.
-
PET/Computed Tomography: Post-therapy Follow-up in Head and Neck Cancer.
-
Parotid gland tumors: preliminary data for the value of FDG PET/CT diagnostic parameters.
-
Partial-volume correction increases estimated dopamine D2-like receptor binding potential and reduces adult age differences.
-
Patient management after noninvasive cardiac imaging results from SPARC (Study of myocardial perfusion and coronary anatomy imaging roles in coronary artery disease).
-
Pattern of failure in anaplastic glioma patients with an IDH1/2 mutation.
-
Patterns of infarction in hemodynamic failure.
-
Patterns of recurrence after trimodality therapy for esophageal cancer.
-
Perceived misinterpretation rates in oncologic 18F-FDG PET/CT studies: a survey of referring physicians.
-
Performance comparison of a dedicated total breast PET system with a clinical whole-body PET system: a simulation study.
-
Perfusion CT compared to H(2) (15)O/O (15)O PET in patients with chronic cervical carotid artery occlusion.
-
Pharmacodynamic study using FLT PET/CT in patients with renal cell cancer and other solid malignancies treated with sunitinib malate.
-
Pharmacological and toxicological evaluation of 2-fluoro-3-(2(S)-azetidinylmethoxy)pyridine (2-F-A-85380), a ligand for imaging cerebral nicotinic acetylcholine receptors with positron emission tomography.
-
PhytoBeta imager: a positron imager for plant biology.
-
Pilot Study of [18F] Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)/Magnetic Resonance Imaging (MRI) for Staging of Muscle-invasive Bladder Cancer (MIBC).
-
Pitfalls of post-treatment PET after de-intensified chemoradiotherapy for HPV-associated oropharynx cancer: Secondary analysis of a phase 2 trial.
-
Platelet mitochondrial complex I and I+III activities do not correlate with cerebral mitochondrial oxidative metabolism.
-
Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
-
Positron emission tomography in hepatobiliary and pancreatic malignancies: a review.
-
Positron emission tomography in radiation treatment planning: the potential of metabolic imaging.
-
Postoperative Surveillance in Older Adults With T1N0M0 Low-risk Papillary Thyroid Cancer.
-
Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?
-
Potential Cardiovascular Applications of Total-body PET Imaging.
-
Potential impact of amyloid imaging on diagnosis and intended management in patients with progressive cognitive decline.
-
Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning.
-
Practical approach to diagnostic CT combined with PET.
-
Pre-treated anti-PD-1 refractory Merkel cell carcinoma successfully treated with the combination of PD-1/PD-L1 axis inhibitors and TVEC: a report of two cases.
-
Preclinical evaluation of 18F-JNJ41510417 as a radioligand for PET imaging of phosphodiesterase-10A in the brain.
-
Predicting cognitive decline in subjects at risk for Alzheimer disease by using combined cerebrospinal fluid, MR imaging, and PET biomarkers.
-
Prediction of lung malignancy progression and survival with machine learning based on pre-treatment FDG-PET/CT.
-
Predictive and prognostic role of functional imaging of head and neck squamous cell carcinomas.
-
Predictors of Left Main Coronary Artery Disease in the ISCHEMIA Trial.
-
Preliminary validation of varicella zoster virus thymidine kinase as a novel reporter gene for PET.
-
Primary surgery versus chemoradiation in the treatment of IB2 cervical carcinoma: a cost effectiveness analysis.
-
Primary tumor standardized uptake value (SUVmax) measured on fluorodeoxyglucose positron emission tomography (FDG-PET) is of prognostic value for survival in non-small cell lung cancer (NSCLC): a systematic review and meta-analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project.
-
Primary tumour standardised uptake value is prognostic in nonsmall cell lung cancer: a multivariate pooled analysis of individual data.
-
Principles and techniques of radiation therapy for esophageal and gastroesophageal junction cancers.
-
Prognosis of conversion of mild cognitive impairment to Alzheimer's dementia by voxel-wise Cox regression based on FDG PET data.
-
Prognostic Value of FDG PET/CT-Derived Parameters in Pancreatic Adenocarcinoma at Initial PET/CT Staging.
-
Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features.
-
Prognostic significance of parameters derived from co-registered 18F-fluorodeoxyglucose PET and contrast-enhanced MRI in patients with high-grade glioma.
-
Prognostic value of 3'-deoxy-3'-18F-fluorothymidine ([(18)F] FLT PET) in patients with recurrent malignant gliomas.
-
Prognostic value of PET myocardial perfusion imaging in obese patients.
-
Prognostic value of Rb-82 positron emission tomography myocardial perfusion imaging in coronary artery bypass patients.
-
Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma.
-
Prognostic value of midtreatment FDG-PET in oropharyngeal cancer.
-
Prognostic value of stress myocardial perfusion positron emission tomography: results from a multicenter observational registry.
-
Progress and promise of FDG-PET imaging for cancer patient management and oncologic drug development.
-
Prospective evaluation of 18F-fluorodeoxyglucose positron emission tomography in patients receiving hepatic arterial and systemic chemotherapy for unresectable colorectal liver metastases.
-
Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer.
-
Quantification of alpha4beta2* nicotinic receptors in the rat brain with microPET and 2-[18F]F-A-85380.
-
Quantification of nicotinic acetylcholine receptors in the human brain with PET: bolus plus infusion administration of 2-[18F]F-A85380.
-
Quantitative effects of contrast enhanced CT attenuation correction on PET SUV measurements.
-
Quantitative imaging in oncology patients: Part 1, radiology practice patterns at major U.S. cancer centers.
-
Quantitative imaging in oncology patients: Part 2, oncologists' opinions and expectations at major U.S. cancer centers.
-
R. Edward Coleman, MD, 1943-2012.
-
Radiofrequency ablation for primary lung cancer and pulmonary metastases.
-
Radiographic imaging of bronchioloalveolar carcinoma: screening, patterns of presentation and response assessment.
-
Radiolabeled inhibitors as probes for imaging mutant IDH1 expression in gliomas: Synthesis and preliminary evaluation of labeled butyl-phenyl sulfonamide analogs.
-
Radiology quiz case 2. Docetaxel (Taxotere)-induced photosensitivity.
-
Radiosensitive orbital metastasis as presentation of occult colonic adenocarcinoma.
-
Randomized Phase II Study of PET Response-Adapted Combined Modality Therapy for Esophageal Cancer: Mature Results of the CALGB 80803 (Alliance) Trial.
-
Randomized controlled trial of intraputamenal glial cell line-derived neurotrophic factor infusion in Parkinson disease.
-
Reactions to Amyloid PET Scan Results and Levels of Anxious and Depressive Symptoms: CARE IDEAS Study.
-
Real-Time Transferrin-Based PET Detects MYC-Positive Prostate Cancer.
-
Real-world effectiveness of preemptive therapy (PET) for cytomegalovirus (CMV) disease prevention in CMV high-risk donor seropositive/recipient seronegative (D+R-) liver transplant recipients (LTxR).
-
Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule.
-
Recent developments in predicting thyroid malignancy.
-
Recommendations on the use of 18F-FDG PET in oncology.
-
Redistribution of health care costs after the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2005.
-
Reduced effects of age on dopamine D2 receptor levels in physically active adults.
-
Reduced serotonin receptors and transporters in normal aging adults: a meta-analysis of PET and SPECT imaging studies.
-
Regional Amyloid-β Load and White Matter Abnormalities Contribute to Hypometabolism in Alzheimer's Dementia.
-
Regional brain activity correlates of nicotine dependence.
-
Regional cerebral blood flow and metabolic rate in persistent Lyme encephalopathy.
-
Regional cerebral glucose metabolism differentiates danger- and non-danger-based traumas in post-traumatic stress disorder.
-
Relative Mean Transit Time Predicts Subsequent Stroke in Symptomatic Carotid Occlusion.
-
Repeatability of 18F-FDG PET/CT in Advanced Non-Small Cell Lung Cancer: Prospective Assessment in 2 Multicenter Trials.
-
Repeatability of hypoxia PET imaging using [¹⁸F]HX4 in lung and head and neck cancer patients: a prospective multicenter trial.
-
Reply to "Prognostic Value of Fluorodeoxyglucose-Positron Emission Tomography".
-
Reply to M.S. Hofman et al.
-
Reply: Pharmacokinetic and Pharmacodynamic Modifiers of EF5 Uptake and Binding.
-
Reply: Repeatability of Tumor SUV Quantification: The Role of Variable Blood SUV.
-
Retinal microvasculature changes in amyloid-negative subcortical vascular cognitive impairment compared to amyloid-positive Alzheimer's disease.
-
Role of Non-FDG-PET/CT in Head and Neck Cancer.
-
Safety of radial arterial catheterization in PET research subjects.
-
Safety, pharmacokinetics, pharmacodynamics, and antitumor activity of dalantercept, an activin receptor-like kinase-1 ligand trap, in patients with advanced cancer.
-
Schwannoma in neurofibromatosis type 1: a pitfall for detecting malignancy by metabolic imaging.
-
Science to practice: Molecular targeting with SPECT/CT and MR imaging in oncology--integration of functional and structural imaging.
-
Selecting a noninvasive imaging study after an inconclusive exercise test.
-
Serum levels of TARC, MDC, IL-10, and soluble CD163 in Hodgkin lymphoma: a SWOG S0816 correlative study.
-
Sex and APOE ε4 genotype modify the Alzheimer's disease serum metabolome.
-
Sex-specific effects of cigarette mentholation on brain nicotine accumulation and smoking behavior.
-
Sharing voxelwise neuroimaging results from rhesus monkeys and other species with Neurovault.
-
Spatial patterns of brain amyloid-beta burden and atrophy rate associations in mild cognitive impairment.
-
Spatial-temporal [¹⁸F]FDG-PET features for predicting pathologic response of esophageal cancer to neoadjuvant chemoradiation therapy.
-
Spatiotemporal distribution modeling of PET tracer uptake in solid tumors.
-
Spontaneous Eye Blink Rate (EBR) Is Uncorrelated with Dopamine D2 Receptor Availability and Unmodulated by Dopamine Agonism in Healthy Adults.
-
Stage migration, selection bias, and survival associated with the adoption of positron emission tomography among medicare beneficiaries with non-small-cell lung cancer, 1998-2003.
-
Staging chest computed tomography and positron emission tomography in patients with pancreatic adenocarcinoma: utility or futility?
-
Subspace Regularized Sparse Multitask Learning for Multiclass Neurodegenerative Disease Identification.
-
Superior prognostic utility of gross and metabolic tumor volume compared to standardized uptake value using PET/CT in head and neck squamous cell carcinoma patients treated with intensity-modulated radiotherapy.
-
Synthesis and biological evaluation of an 123I-labeled bicyclic nucleoside analogue (BCNA) as potential SPECT tracer for VZV-tk reporter gene imaging.
-
Synthesis and evaluation of 18F- and 11C-labeled phenyl-galactopyranosides as potential probes for in vivo visualization of LacZ gene expression using positron emission tomography.
-
Synthesis and evaluation of 18F-labeled benzylguanidine analogs for targeting the human norepinephrine transporter.
-
Synthesis and evaluation of 4-[18F]fluoropropoxy-3-iodobenzylguanidine ([18F]FPOIBG): A novel 18F-labeled analogue of MIBG.
-
Synthesis and preliminary evaluation of 18F- or 11C-labeled bicyclic nucleoside analogues as potential probes for imaging varicella-zoster virus thymidine kinase gene expression using positron emission tomography.
-
Synthesis and structure-activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography.
-
Synthesis, fluorine-18 radiolabeling, and in vitro characterization of 1-iodophenyl-N-methyl-N-fluoroalkyl-3-isoquinoline carboxamide derivatives as potential PET radioligands for imaging peripheral benzodiazepine receptor.
-
Synthetic positron emission tomography-computed tomography images for use in perceptual studies.
-
Task Group 174 Report: Utilization of [18 F]Fluorodeoxyglucose Positron Emission Tomography ([18 F]FDG-PET) in Radiation Therapy.
-
Technical considerations in radiation therapy for gastroesophageal junction cancer.
-
Temporoparietal hypometabolism in frontotemporal lobar degeneration and associated imaging diagnostic errors.
-
The Alzheimer structural connectome: changes in cortical network topology with increased amyloid plaque burden.
-
The BIN1 rs744373 SNP is associated with increased tau-PET levels and impaired memory.
-
The Carotid Occlusion Surgery Study.
-
The Current and Evolving Role of PET in Personalized Management of Lung Cancer.
-
The Pedunculated Pretender: A Case of Invasive Anorectal Mucosal Melanoma.
-
The Role of Positron Emission Tomography/Computed Tomography in Management and Prediction of Survival in Pancreatic Cancer.
-
The added value of 18F-FDG PET/CT for evaluation of patients with esthesioneuroblastoma.
-
The development of a population of 4D pediatric XCAT phantoms for imaging research and optimization.
-
The immune response of the human brain to abdominal surgery.
-
The impact of radiation therapy in patients with diffuse large B-cell lymphoma with positive post-chemotherapy FDG-PET or gallium-67 scans.
-
The neurobiology of individual differences in complex behavioral traits.
-
The prognostic value of interim and end-of-treatment PET/CT in patients with newly diagnosed peripheral T-cell lymphoma.
-
The role of PET/CT in the management of cervical cancer.
-
The role of adaptive and functional imaging modalities in radiation therapy: approach and application from a radiation oncology perspective.
-
The triangular intermuscular space as a site of lymph node metastasis in melanoma of the back.
-
The utility of F-18 fluorodeoxyglucose whole body PET imaging for determining malignancy in cystic lesions of the pancreas.
-
The utility of FDG-PET for assessing outcomes in oligometastatic cancer patients treated with stereotactic body radiotherapy: a cohort study.
-
The value of [(18)F]fluorodeoxyglucose positron emission tomography/computed tomography in extranodal natural killer/T-cell lymphoma.
-
The value of diagnostic medical imaging.
-
Therapeutic tools in pancreatic cancer.
-
Therapy Response Assessment and Patient Outcomes in Head and Neck Squamous Cell Carcinoma: FDG PET Hopkins Criteria Versus Residual Neck Node Size and Morphologic Features.
-
Thoracic imaging.
-
Thyroid carcinoma: the surgeon's perspective.
-
Tracking radiation exposure of patients.
-
Transient focal increase in perihematomal glucose metabolism after acute human intracerebral hemorrhage.
-
Treatment for tobacco dependence: effect on brain nicotinic acetylcholine receptor density.
-
Trithiols and their arsenic compounds for potential use in diagnostic and therapeutic radiopharmaceuticals.
-
Tumor blood flow measured by PET dynamic imaging of first-pass 18F-FDG uptake: a comparison with 15O-labeled water-measured blood flow.
-
Tumor blood flow measured by perfusion computed tomography and 15O-labeled water positron emission tomography: a comparison study.
-
Tumor necrosis and cavitation after stereotactic body radiation therapy.
-
Two-time-point FDG PET/CT: liver SULmean repeatability.
-
Up-regulation of nicotinic acetylcholine receptors in menthol cigarette smokers.
-
Use of 18F-FDG PET/CT as a predictive biomarker of outcome in patients with head-and-neck non-squamous cell carcinoma.
-
Use of 18F-Fludeoxyglucose-Positron Emission Tomography/Computed Tomography for Patient Management and Outcome in Oropharyngeal Squamous Cell Carcinoma: A Review.
-
Use of Multimodality Imaging in Diagnosing Invasive Fungal Diseases of the Heart.
-
Use of florbetapir-PET for imaging beta-amyloid pathology.
-
Using FDG-PET activity as a surrogate for tumor cell density and its effect on equivalent uniform dose calculation.
-
Using FDG-PET to measure early treatment response in head and neck squamous cell carcinoma: quantifying intrinsic variability in order to understand treatment-induced change.
-
Using positron emission tomography and florbetapir F18 to image cortical amyloid in patients with mild cognitive impairment or dementia due to Alzheimer disease.
-
Using the 3-tiered system for categorizing workup of incidental thyroid nodules detected on CT, MRI, or PET/CT: how many cancers would be missed?
-
Utility of FDG PET/CT in inflammatory cardiovascular disease.
-
Utility of functional imaging in prediction or assessment of treatment response and prognosis following thermotherapy.
-
Utility of integrated computed tomography-positron emission tomography for selection of operable malignant pleural mesothelioma.
-
Utilizing 18F-fluoroethyltyrosine (FET) positron emission tomography (PET) to define suspected nonenhancing tumor for radiation therapy planning of glioblastoma.
-
Validation of an extracerebral reference region approach for the quantification of brain nicotinic acetylcholine receptors in squirrel monkeys with PET and 2-18F-fluoro-A-85380.
-
Validation of consensus panel diagnosis in dementia.
-
Value of FDG PET/CT in Patient Management and Outcome of Skeletal and Soft Tissue Sarcomas.
-
Value of Fluorodeoxyglucose PET/Computed Tomography Patient Management and Outcomes in Thyroid Cancer.
-
Value of PET/CT in the management of primary hepatobiliary tumors, part 2.
-
Value of imaging in head and neck tumors.
-
Variable-time positron emission tomography leg protocol to equalize noise for positron emission tomography/computed tomography acquisitions.
-
Variations in use of PET among Medicare beneficiaries with non-small cell lung cancer, 1998-2007.
-
Ventilation defects observed with hyperpolarized 3He magnetic resonance imaging in a mouse model of acute lung injury.
-
Ventral striatal dopamine transporter availability is associated with lower trait motor impulsivity in healthy adults.
-
Vulnerable plaque intervention: State of the art.
-
Waldenström macroglobulinemia with extramedullary involvement at initial diagnosis portends a poorer prognosis.
-
When is a biopsy-proven diagnosis necessary before stereotactic ablative radiotherapy for lung cancer?: A decision analysis.
-
Willingness to Undergo a Risky Treatment to Improve Cognition Among Persons With Cognitive Impairment Who Received an Amyloid PET Scan.
-
[18F]-fluorodeoxyglucose positron emission tomography combined with computed tomography detection of asymptomatic late pulmonary toxicity in patients with non-Hodgkin lymphoma treated with rituximab-containing chemotherapy.
-
[18F]Fluoro-L-dopa PET/CT in congenital hyperinsulinism.
-
[18F]fluorodeoxyglucose-positron emission tomography in patients with medulloblastoma.
-
[18
F]Fluoro-DCP, a first generation PET radiotracer for monitoring protein sulfenylation in vivo.
-
¹⁸F-FDG PET/CT and Colorectal Cancer: Value of Fourth and Subsequent Posttherapy Follow-up Scans for Patient Management.
-
Keywords of People
-
Chitneni, Satish K.,
Associate Professor in Radiology,
Radiology
-
Curtis, Lesley H.,
Professor in Population Health Sciences,
Medicine, General Internal Medicine
-
Esclamado, Ramon Mitra,
Richard Hall Chaney, Sr. Distinguished Professor Emeritus of Otolaryngology,
Head and Neck Surgery & Communication Sciences
-
McLendon, Roger Edwin,
Professor of Pathology,
Pathology
-
Palmer, Gregory M.,
Associate Professor of Radiation Oncology,
Radiation Oncology
-
Patz Jr., Edward F.,
James and Alice Chen Distinguished Professor of Radiology,
Pathology
-
Sampson, John Howard,
Robert H., M.D. and Gloria Wilkins Professor of Neurosurgery, in the School of Medicine,
Biomedical Engineering
-
Segars, William Paul,
Associate Professor in Radiology,
Radiology
-
Sullivan, Daniel Carl,
Professor Emeritus of Radiology,
Radiology
-
Turkington, Timothy Garvey,
Associate Professor in Radiology,
Radiology
-
Turner, Dennis Alan,
Professor of Neurosurgery,
Biomedical Engineering